Mel DeCorby

514 total citations
11 papers, 412 citations indexed

About

Mel DeCorby is a scholar working on Infectious Diseases, Molecular Medicine and Epidemiology. According to data from OpenAlex, Mel DeCorby has authored 11 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Molecular Medicine and 4 papers in Epidemiology. Recurrent topics in Mel DeCorby's work include Antimicrobial Resistance in Staphylococcus (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Mel DeCorby is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (7 papers), Antibiotic Resistance in Bacteria (6 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Mel DeCorby collaborates with scholars based in Canada. Mel DeCorby's co-authors include George G. Zhanel, Philippe Lagacé‐Wiens, James A. Karlowsky, Aleksandra Wierzbowski, Michael R. Mulvey, Kim Nichol, Daryl J. Hoban, Patricia J. Baudry, Andrew Walkty and Melissa McCracken and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Diagnostic Microbiology and Infectious Disease and Expert Review of Anti-infective Therapy.

In The Last Decade

Mel DeCorby

11 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mel DeCorby Canada 8 216 130 130 115 110 11 412
Marcello Meledandri Italy 11 314 1.5× 178 1.4× 98 0.8× 105 0.9× 158 1.4× 14 502
C. J. Henwood United Kingdom 7 281 1.3× 110 0.8× 164 1.3× 70 0.6× 115 1.0× 7 462
Donatella Lombardo Italy 11 289 1.3× 168 1.3× 125 1.0× 133 1.2× 163 1.5× 19 551
Jun-Hee Woo South Korea 7 186 0.9× 127 1.0× 77 0.6× 65 0.6× 68 0.6× 14 346
Aura Lucía Leal Colombia 15 154 0.7× 170 1.3× 223 1.7× 167 1.5× 48 0.4× 61 557
Mohamad Yasmin United States 11 255 1.2× 135 1.0× 81 0.6× 90 0.8× 150 1.4× 20 410
F. C. Tenover United States 6 120 0.6× 115 0.9× 128 1.0× 111 1.0× 73 0.7× 8 368
Wasan Katip Thailand 16 241 1.1× 181 1.4× 133 1.0× 76 0.7× 217 2.0× 39 514
Sergio García‐Fernández Spain 13 237 1.1× 120 0.9× 173 1.3× 86 0.7× 138 1.3× 34 523
Arlene A. Obias United States 7 216 1.0× 151 1.2× 144 1.1× 73 0.6× 68 0.6× 8 377

Countries citing papers authored by Mel DeCorby

Since Specialization
Citations

This map shows the geographic impact of Mel DeCorby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mel DeCorby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mel DeCorby more than expected).

Fields of papers citing papers by Mel DeCorby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mel DeCorby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mel DeCorby. The network helps show where Mel DeCorby may publish in the future.

Co-authorship network of co-authors of Mel DeCorby

This figure shows the co-authorship network connecting the top 25 collaborators of Mel DeCorby. A scholar is included among the top collaborators of Mel DeCorby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mel DeCorby. Mel DeCorby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Lagacé‐Wiens, Philippe, Mel DeCorby, Patricia J. Baudry, et al.. (2009). Analysis of 1560 Inpatient and Outpatient Escherichia coli Isolates from across Canada—Results from the CANWARD 2007 Study. Canadian Journal of Infectious Diseases and Medical Microbiology. 20(A). 1 indexed citations
2.
Zhanel, George G., Mel DeCorby, Kim Nichol, et al.. (2009). Antimicrobial Susceptibility of 6685 Organisms Isolated from Canadian Hospitals: CANWARD 2007. Canadian Journal of Infectious Diseases and Medical Microbiology. 20(A). 2 indexed citations
3.
Zhanel, George G., James A. Karlowsky, Mel DeCorby, et al.. (2009). Prevalence of Antimicrobial‐Resistant Pathogens in Canadian Hospitals: Results of the Canadian Ward Surveillance Study (CANWARD 2007). Canadian Journal of Infectious Diseases and Medical Microbiology. 20(A). 16 indexed citations
4.
Karlowsky, James A., Mel DeCorby, Daryl J. Hoban, & George G. Zhanel. (2009). In Vitro Activities of Ceftobiprole and Doripenem Tested against Frequently Encountered Aerobic and Facultative Gram‐Positive and Gram‐Negative Bacterial Pathogens Isolated from Patients in Canadian Hospitals in 2007. Canadian Journal of Infectious Diseases and Medical Microbiology. 20(A). 2 indexed citations
5.
Zhanel, George G., Mel DeCorby, Kim Nichol, et al.. (2008). Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006. Diagnostic Microbiology and Infectious Disease. 62(1). 67–80. 51 indexed citations
6.
7.
Zhanel, George G., Alfred S. Gin, Mel DeCorby, et al.. (2008). Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections. Expert Review of Anti-infective Therapy. 6(1). 67–81. 46 indexed citations
8.
Zhanel, George G., Mel DeCorby, Nancy M. Laing, et al.. (2008). Antimicrobial-Resistant Pathogens in Intensive Care Units in Canada: Results of the Canadian National Intensive Care Unit (CAN-ICU) Study, 2005-2006. Antimicrobial Agents and Chemotherapy. 52(4). 1430–1437. 215 indexed citations
9.
Lagacé‐Wiens, Philippe, Kim Nichol, Lindsay E. Nicolle, et al.. (2006). ESBL Genotypes in Fluoroquinolone‐Resistant and Fluoroquinolone‐Susceptible ESBL‐Producing Escherichia coli Urinary Isolates in Manitoba. Canadian Journal of Infectious Diseases and Medical Microbiology. 18(2). 133–137. 19 indexed citations
10.
Wierzbowski, Aleksandra, Daryl J. Hoban, Tamiko Hisanaga, Mel DeCorby, & George G. Zhanel. (2006). The use of macrolides in treatment of upper respiratory tract infections. Current Allergy and Asthma Reports. 6(2). 171–181. 18 indexed citations
11.
Wierzbowski, Aleksandra, Daryl J. Hoban, Tamiko Hisanaga, Mel DeCorby, & George G. Zhanel. (2005). The use of macrolides in treatment of upper respiratory tract infections. Current Infectious Disease Reports. 7(3). 175–184. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcello Meledandri Breakdown of academic impact, for papers by C. J. Henwood Breakdown of academic impact, for papers by Donatella Lombardo Breakdown of academic impact, for papers by Jun-Hee Woo Breakdown of academic impact, for papers by Aura Lucía Leal Breakdown of academic impact, for papers by Mohamad Yasmin Breakdown of academic impact, for papers by F. C. Tenover Breakdown of academic impact, for papers by Wasan Katip Breakdown of academic impact, for papers by Sergio García‐Fernández Breakdown of academic impact, for papers by Arlene A. Obias
Rankless by CCL
2026